Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system.
Cognitive impairment in patients with multiple sclerosis predicts worse caregiver's health-related quality of life.
Gender and Uveitis in Patients with Multiple Sclerosis.
Acute bilateral visual loss in a young adult.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
Retinal thickness in pediatric multiple sclerosis.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Association of fish consumption and omega 3 supplementation with quality of life, disability and disease activity in an international cohort of people with multiple sclerosis.
Cerebral Cortex Involvement in Neuromyelitis Optica Spectrum Disorder.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
Acceptance of the Extracare Program by Beta Interferon-Treated Patients With Multiple Sclerosis: Results of the Explore Study.
Probabilistic Multiple Sclerosis Lesion Classification based on Modelling Regional Intensity Variability and Local Neighbourhood Information.
Nutrition Facts in Multiple Sclerosis.
Associated Inosine to interferon: results of a clinical trial in multiple sclerosis.
Examining multiple sclerosis through the eyes of a child.
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Nogo Receptor Inhibition Enhances Functional Recovery following Lysolecithin-Induced Demyelination in Mouse Optic Chiasm.
Functional Cognitive Disorder: A Common Cause of Subjective Cognitive Symptoms.
Therapeutics to Promote CNS Repair: A Natural Human Neuron-Binding IgM Regulates Membrane-Raft Dynamics and Improves Motility in a Mouse Model of Multiple Sclerosis.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »